Back

Substernal lead removal: experience from the EV ICD pivotal study

8 April 2024 (13:57 - 14:06)
Organised by: Logo
Congress Presentation Part of: ICD and remote monitoring Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Anish Amin

OhioHealth Riverside Methodist Hospital, Columbus (United States of America)

5 More presentations in this session

Presentation thumbnail
Feasibility of left bundle branch area defibrillator implantation using three-dimensional delivery systems and traditional high voltage leads
Doctor C. Mandurino (Taranto, IT)
Abstract Slides Video
Presentation thumbnail
Early relevant alerts from remote monitoring in heart failure patients with a cardiac implanted electronic device: what implications for long term outcome?
Doctor D. Mei (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences among S-ICD recipients: a propensity-matched, multicenter, international analysis from the i-SUSI project
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Enhancing heart failure management: a comprehensive analysis of continuous remote monitoring vs. standard care in patients with cardiac implantable electronic devices
Doctor B. Veres (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic role of pre-ICD implantation magnetic resonance: a longitudinal cohort study
Doctor M. Spoladori (Parma, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ICD and remote monitoring
Video

The Event

Event poster

EHRA 2024

8 April 2024 13:57 CET
You may be interested in
thumbnail
Congress Presentation
Performance and safety of the extravascular ICD
thumbnail
Congress Presentation
EV-ICD performance over time
thumbnail
Congress Presentation
Infection management in the extravascular implantable cardioverter defibrillator: experience from the EV ICD Pivotal study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources